<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941205-2-00028</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>National Institutes of Health</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Government-Owned Inventions; Availability for Licensing </DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  National Institutes of Health, HHS. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Notice.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The inventions listed below are owned by agencies of the U.S.  <!-- PJG 0012 frnewline --> Government and are available for licensing in the U.S. in  <!-- PJG 0012 frnewline --> accordance with 35 U.S.C. 207 to achieve expeditious  <!-- PJG 0012 frnewline --> commercialization of results of federally funded research and  <!-- PJG 0012 frnewline --> development. Foreign patent applications are filed on selected  <!-- PJG 0012 frnewline --> inventions to extend market coverage for U.S. companies and may  <!-- PJG 0012 frnewline --> also be available for licensing.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </ACTION> <ADDRESS> <!-- PJG ITAG l=10 g=1 f=2 --> ADDRESSES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Licensing information and copies of the U.S. patent  <!-- PJG 0012 frnewline --> applications listed below may be obtained by contacting  <!-- PJG 0012 frnewline --> Leopold J. Luberecki, Jr., J.D., Technology Licensing Specialist,  <!-- PJG 0012 frnewline --> Office of Technology Transfer, National Institutes of Health,  <!-- PJG 0012 frnewline --> 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852&hyph;3804 (telephone 301/496&hyph;7735 ext. 223; fax 301/402&hyph;0220). A  <!-- PJG 0012 frnewline --> signed Confidential Disclosure Agreement will be required to  <!-- PJG 0012 frnewline --> receive copies of the patent applications. Issued patents may be obtained from the Commissioner of Patents, U.S. Patent and  <!-- PJG 0012 frnewline --> Trademark Office, Washington, DC 20231.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Recombinant Vaccinia Virus Encoding Cytochromes P&hyph;450  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=16 g=1 f=1 --> Gelboin, H.V., Battula, N., Gonzalez, F.J., Moss, B. (NCI, NIAID)  <!-- PJG 0012 frnewline --> Serial No. 07/787,777 filed 6 Nov 91  <!-- PJG 0012 frnewline --> U.S. Patent 5,164,313 issued 17 Nov 92  <!-- PJG 0012 frnewline --> Serial No. 08/166,287  <!-- PJG 0012 frnewline --> Filed 13 Dec 93 [FWC of 07/930,781 (Aban), which is DIV of  <!-- PJG 0012 frnewline --> 07/787,777] <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> This invention describes the construction and uses of  <!-- PJG 0012 frnewline --> recombinant vaccinia viruses containing DNA sequences that  <!-- PJG 0012 frnewline --> express enzymatically active cytochromes P1&hyph;450 and P3&hyph;450 in  <!-- PJG 0012 frnewline --> mammalian cells without requiring the extraneous addition of  <!-- PJG 0012 frnewline --> NADPH cytochrome P450 reductase or cell fractions for catalytic  <!-- PJG 0012 frnewline --> activity. This novel recombinant virus can be used to evaluate  <!-- PJG 0012 frnewline --> the cytochrome P&hyph;450-mediated metabolism and mutagenicity of  <!-- PJG 0012 frnewline --> xenobiotic or endobiotic compounds and chemical agents. The  <!-- PJG 0012 frnewline --> invention represents the first expression of cytochrome P&hyph;450 in  <!-- PJG 0012 frnewline --> a variety of mammalian systems using infectious viruses.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=85 g=1 f=1 --> Chemotherapeutic Agent Evaluation Using Cells Grown In Hollow  <!-- PJG 0012 frnewline --> Fibers In Vivo  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=16 g=1 f=1 --> Hollingshead, M.G. (NCI)  <!-- PJG 0012 frnewline --> Filed 5 May 93  <!-- PJG 0012 frnewline --> Serial No. 08/058,154  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </ADDRESS> <!-- PJG /STAG --></p>
		</main>
</body></html>
            